Roche
Top stories
- Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions3 outlets · 2026-10-01 07:12 UTC
Latest
- Breast cancer drug Roche, CDK4/6 after progression risk 44%↓cdn.medipana.com · 2026-10-02 23:57 UTC · story
- Stock market ticker: SMI with slight recovery - New price targets and ratings for Swiss stocks - ABB and Amrize in demand - Roche with losses - Focus on US labor market datacash.ch · 2026-10-02 05:39 UTC · story
- Roche HER2 positive breast cancer treatment has a social value of 800 billion won... 63% are in early treatmentetoday.co.kr · 2026-10-01 08:43 UTC · story
- Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditionsGlobeNewswire — public companies · 2026-10-01 06:00 UTC · 2 more reports
- Roche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of MedicineGlobeNewswire — public companies · 2026-10-01 05:00 UTC · 1 more reports
- Roche publishes detailed Giredestrant data in a medical journalcash.ch · 2026-10-01 05:22 UTC · story
- Roche, Zealand see phase 2 amylin weight loss peak at mid-dose, start pivotal programfiercebiotech.com · 2026-09-30 09:56 UTC · story
- Roche Unveils Newborn Screening Test For 3 Genetic Conditions Of SMA, SCID, Sickle Cell Diseaserttnews.com · 2026-09-30 06:20 UTC · 1 more reports
- Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosisGlobeNewswire — all · 2026-09-30 05:00 UTC · 2 more reports
- Stock Market Ticker: SMI starts positively – Roche in demand after MS drug announcement – DocMorris expands profits – Lindt&Sprüngli lossescash.ch · 2026-09-30 03:04 UTC · story
- Roche installs its first massive sequencing equipment in Spain at the National Center for Genomic Analysisinfosalus.com · 2026-09-29 11:02 UTC · story
- Roche develops laboratories for the development of new AI-managed drugstportal.hr · 2026-09-28 15:18 UTC · 3 more reports
- AI pharmaceutical manufacturing welcomes another giant investment: Roche plans automated laboratories, targeting 2...news.baidu.com · 2026-09-29 03:32 UTC · story
- Roche introduces'self-experimenting AI lab' for new drug researchcdn.medipana.com · 2026-09-29 00:20 UTC · story
- Can Roche's Latest Obesity Drug Results Help it Challenge Eli Lilly and Novo Nordisk?insidermonkey.com · 2026-09-28 22:39 UTC · story
- Roche drops obesity antibody after flunked interim analysisfiercebiotech.com · 2026-09-28 19:37 UTC · story
- Chugai Regains Emugrobart Rights After Roche Discontinuation, Stock Downrttnews.com · 2026-09-28 15:50 UTC · story
- AI at heart of Roche's future strategyswissinfo.ch · 2026-09-28 12:56 UTC · story
- Roche focuses on speed at Pharma Day - Important questions and answerscash.ch · 2026-09-28 11:47 UTC · 1 more reports
- Chugai Set to Reclaim Myostatin Drug Rights From Roche After Obesity Trial Falls Shorttokyobrief.com · 2026-09-28 11:54 UTC · story
- Pharmaceutical company: Roche trims research for efficiency and aims for 20 new drugshandelsblatt.com · 2026-09-28 10:16 UTC · story
- Roche showcases its success rate in phase IIIbluewin.ch · 2026-09-28 09:54 UTC · story
- Roche subsidiary Chugai ends development of Emugrobart for obesitycash.ch · 2026-09-28 07:44 UTC · story
- Stock Market Ticker: US markets lower before start - SMI barely in the plus - Novartis impresses - Roche lags behindcash.ch · 2026-09-28 04:20 UTC · 2 more reports
- Roche partners to discover new drugs for CVRM diseasesbosa.co.kr · 2026-09-28 02:27 UTC · story
- Roche partners to discover dual-specificity anti-cancer antibodies in Chinabosa.co.kr · 2026-09-28 02:10 UTC · story